某多医院医疗网络内部自制病毒运输培养基支持SARS-CoV-2 PCR检测的大规模生产
COVID-19大流行导致全球病毒运输培养基(VTM)供应短缺。某医院网络因诊断实验室无法生产试剂,利用研究部门关闭后空出的空间和人员,按CDC配方自制VTM。基于加标实验的循环阈值(CT),自制VTM在Abbott m2000平台上的Abbott RealTime SARS-CoV-2 EUA检测中支持高度一致的靶标扩增(变异系数=2.95%),且与多种拭子兼容,加速稳定性研究显示室温下至少4个月保持功能。
要点
- 自制VTM按CDC配方生产,无需过滤除菌,使用商业可得试剂。
- 加标实验显示SARS-CoV-2靶标扩增变异系数为2.95%。
- 自制VTM与多种拭子兼容,室温下至少4个月保持功能。
核心结论
- 在COVID-19大流行导致VTM短缺的背景下,医院网络可内部大规模生产VTM以支持SARS-CoV-2 RT-PCR检测。
研究设计与样本
- 本文为某多医院医疗网络内部生产VTM的经验报告,利用研究部门关闭后空出的空间和人员,按CDC配方生产VTM,并通过多项质量保证措施评估性能。
主要发现
- 基于加标实验的循环阈值(CT),自制VTM在Abbott m2000平台上的Abbott RealTime SARS-CoV-2 EUA检测中支持高度一致的SARS-CoV-2靶标扩增,变异系数=2.95%。
- 自制VTM与多种拭子类型兼容。
- 基于加速稳定性研究,自制VTM在室温下至少4个月保持功能。
关键数值与推荐
- 自制VTM支持SARS-CoV-2靶标扩增的变异系数=2.95%(基于加标实验的CT值)。
- 加速稳定性研究显示自制VTM在室温下至少4个月保持功能。
临床怎么用
- 在VTM供应短缺时,检验科可参考CDC配方在内部生产VTM,并采用加标实验、拭子兼容性测试和加速稳定性研究进行质量保证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 pandemic has severely disrupted worldwide supplies of viral transport media (VTM) due to widespread demand for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-PCR (RT-PCR) testing. In response to this ongoing shortage, we began production of VTM in-house in support of diagnostic testing in our hospital network. As our diagnostic laboratory was not equipped for reagent production, we took advantage of space and personnel that became available due to closure of the research division of our medical center. We utilized a formulation of VTM described by the CDC that was simple to produce, did not require filtration for sterilization, and used reagents that were available from commercial suppliers. Performance of VTM was evaluated by several quality assurance measures. Based on cycle threshold (CT ) values of spiking experiments, we found that our VTM supported highly consistent amplification of the SARS-CoV-2 target (coefficient of variation = 2.95%) using the Abbott RealTime SARS-CoV-2 Emergency Use Authorization (EUA) assay on the Abbott m2000 platform. VTM was also found to be compatible with multiple swab types and, based on accelerated stability studies, able to maintain functionality for at least 4 months at room temperature. We further discuss how we met logistical challenges associated with large-scale VTM production in a crisis setting, including use of a staged assembly line for VTM transport tube production.
引用
- Smith KP, Cheng A, Chopelas A, et al. Large-Scale, In-House Production of Viral Transport Media To Support SARS-CoV-2 PCR Testing in a Multihospital Health Care Network during the COVID-19 Pandemic. J Clin Microbiol. 2020. PMID: 32404481. doi:10.1128/JCM.00913-20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。